Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Respirology (Carlton, Vic.)|April 30, 2023
Contemporary Concise Review 2022: Interstitial lung diseaseDavid J F Smith, R Gisli Jenkins
The Journal of Clinical Investigation|September 15, 2023
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosisJames May, Jane A Mitchell, R Gisli Jenkins
The Lancet. Respiratory Medicine|May 19, 2020
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapyPeter M George, Athol U Wells, R Gisli Jenkins
Science (New York, N.Y.)|December 5, 2024
Imperfect wound healing sets the stage for chronic diseasesPaul Martin, Carlos Pardo-Pastor, R Gisli Jenkins, et al.
Clinics in Chest Medicine|April 21, 2023
COVID-19 in Patients with Chronic Lung DiseaseJessica Fae Calver, Laura Fabbri, James May, et al.
The European Respiratory Journal|September 30, 2021
A systematic review of blood biomarkers with individual participant data meta-analysis of matrix metalloproteinase-7 in idiopathic pulmonary fibrosisFasihul A Khan, Iain Stewart, Gauri Saini, et al.
The Journal of Gene Medicine|February 24, 2004
Efficient transfection of non-proliferating human airway epithelial cells with a synthetic vector systemQing-Hai Meng, Danielle Robinson, R Gisli Jenkins, et al.
ERJ Open Research|November 15, 2023
Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertensionGina Parcesepe, Richard J Allen, Beatriz Guillen-Guio, et al.
The Lancet. Respiratory Medicine|May 22, 2023
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitationSally J Singh, Molly M Baldwin, Enya Daynes, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2022
Three-Month FVC Change: A Trial Endpoint for Idiopathic Pulmonary Fibrosis Based on Individual Participant Data Meta-analysisFasihul A Khan, Iain Stewart, Samuel Moss, et al.
Pageof 10